Robert L. Rosiello

2015

In 2015, Robert L. Rosiello earned a total compensation of $60.4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.

Compensation breakdown

Bonus$6,000,000
Non-Equity Incentive Plan$712,184
Salary$546,154
Stock Awards$53,126,290
Other$13,770
Total$60,398,398

Rosiello received $53.1M in stock awards, accounting for 87.96% of the total pay in 2015.

Rosiello also received $6M in bonus, $712.2K in non-equity incentive plan, $546.2K in salary and $13.8K in other compensation.

Rankings

In 2015, Robert L. Rosiello's compensation ranked 9th out of 13,615 executive pay records tracked by us. In other words, Rosiello earned more than 99.9% of all executives tracked by us in 2015.

ClassificationRankingPercentile
All
9
out of 13,615
100th
Manufacturing
Division
5
out of 5,190
100th
Chemicals And Allied Products
Major group
4
out of 1,824
100th
Drugs
Industry group
4
out of 1,493
100th
Pharmaceutical Preparations
Industry
3
out of 1,153
100th
Source: SEC filing on April 29, 2016.

Rosiello's colleagues

We found six more compensation records of executives who worked with Robert L. Rosiello at Valeant Pharmaceuticals International in 2015.

2015

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2015

Anne Whitaker

Valeant Pharmaceuticals International

Group Chairman

2015

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2015

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2015

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2015

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like